Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MicroMend is the commercial wound-closure business and product line developed by Seattle-based KitoTech Medical. The company markets microMend and microMend PRO, adhesive wound-closure devices that incorporate miniature "Microstaples" to provide suture-like holding strength with bandage-like ease of use. Its products are positioned as painless, rapid alternatives to sutures and staples for closing lacerations, surgical incisions, skin tears, and other superficial wounds in both consumer and professional care settings. The business originated from technology spun out of the University of Washington and has been commercialized in U.S. healthcare and retail channels. MicroMend appears to be an active private medtech company or brand business rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MicroMend.